| Russell Beckstead, DO | |
|
5 E 400 N, Springville, UT 84663 | |
| (801) 489-8464 | |
| (801) 798-8513 |
| Full Name | Russell Beckstead |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 5 E 400 N, Springville, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609262492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 10521680-1204 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Canyon View Medical Group Llc | 9739084351 | 36 |
News Archive
As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.
The Brain & Behavior Research Foundation today announced the award of NARSAD Distinguished Investigator Grants valued at $1.5 million to 15 scientists, who are full professors or the equivalent, conducting innovative projects in diverse areas of neurobiological and behavioral research.
Carbon nanotubes, one of the original engineered nanomaterials, also may prove to be among the most versatile, as numerous teams of investigators continue to develop novel nanotube-based therapeutic and diagnostic tools. Over the past month, three new research papers have highlighted the potential of nanotubes as weapons against cancer.
Zalicus Inc. presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Meeting in Berlin, Germany on November 18, 2010.
› Verified 3 days ago
| Entity Name | Canyon View Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477709772 PECOS PAC ID: 9739084351 Enrollment ID: O20031205000226 |
News Archive
As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.
The Brain & Behavior Research Foundation today announced the award of NARSAD Distinguished Investigator Grants valued at $1.5 million to 15 scientists, who are full professors or the equivalent, conducting innovative projects in diverse areas of neurobiological and behavioral research.
Carbon nanotubes, one of the original engineered nanomaterials, also may prove to be among the most versatile, as numerous teams of investigators continue to develop novel nanotube-based therapeutic and diagnostic tools. Over the past month, three new research papers have highlighted the potential of nanotubes as weapons against cancer.
Zalicus Inc. presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Meeting in Berlin, Germany on November 18, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Russell Beckstead, DO 5 E 400 N, Springville, UT 84663-1347 Ph: (801) 489-8464 | Russell Beckstead, DO 5 E 400 N, Springville, UT 84663 Ph: (801) 489-8464 |
News Archive
As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.
The Brain & Behavior Research Foundation today announced the award of NARSAD Distinguished Investigator Grants valued at $1.5 million to 15 scientists, who are full professors or the equivalent, conducting innovative projects in diverse areas of neurobiological and behavioral research.
Carbon nanotubes, one of the original engineered nanomaterials, also may prove to be among the most versatile, as numerous teams of investigators continue to develop novel nanotube-based therapeutic and diagnostic tools. Over the past month, three new research papers have highlighted the potential of nanotubes as weapons against cancer.
Zalicus Inc. presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Meeting in Berlin, Germany on November 18, 2010.
› Verified 3 days ago
Dr. Michael S Mclay, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 E 400 N, Springville, UT 84663 Phone: 801-489-8464 Fax: 801-489-6378 | |
William David Voss, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 376 E 400 S, Springville, UT 84663 Phone: 801-491-9355 Fax: 801-491-3000 | |
Stephen Takasaki, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5 E 400 N, Springville, UT 84663 Phone: 801-489-8464 Fax: 801-798-8513 | |
Dr. Edward William Jackson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 786 S Left Hand Fork Hobble Creek Cyn, Springville, UT 84663 Phone: 801-489-9381 | |
Ian Mcmaster, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 672 W. 400 S., Suite 101, Springville, UT 84663 Phone: 801-491-9883 Fax: 801-489-3141 | |
Don L Bowcut, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 385 S 400 E, Springville, UT 84663 Phone: 801-489-3244 |